DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, announced it has secured $3.5 million in seed funding from a prominent, family office. This significant investment solidifies the company's operational runway for the next 18 months, enabling key advancements in its platform technology..

DNA纳米机器人公司是自组装纳米治疗领域的先驱，宣布已从一家著名的家族理财办公室获得了350万美元的种子资金。这项重要的投资巩固了公司未来18个月的运营资金，使其平台技术能够取得关键进展。